NBY - NovaBay Pharmaceuticals, Inc.
0.564
-0.006 -1.099%
Share volume: 87,946
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.57
-0.01
-0.01%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-07-2024 | |
| Cash flow financing | 2.089 M | |
| Other financing cash flows | 21.000 K | |
| Cash flow | 26.000 K | |
| Net income | -1.212 M | |
| Depreciation | 9.000 K | |
| Changes in inventories | 0.000 | |
| Changes in receivables | 0.000 | |
| Investing Cashflow | -2.000 K | |
| Net Borrowings | 0.000 | |
| Investing Activity Other | 0.000 | |
| Dividends Paid | 0.000 | |
| Exchange Rate Effect | 0.000 | |
| Capital Expenditures | 2.000 K | |
| Cash Change | 26.000 K |
